Science Explorer Back to mapMap
Discussion
Hospital / health system · Nashville · United States

Tennessee Oncology

In research, Tennessee Oncology stands highest in Health Sciences (#2,562 of 9,902 worldwide) and Medicine (#2,878 of 8,541 worldwide), 2022-now. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine (Oncology is 20.8× its share of world research).

tnoncology.comROR OpenAlex
World rank, 2022-now
#13,677
of 22,385 · #9,806 all time
Rank in United States
#1,920
of 3,332
Research works
601
◆ 1% vs 2018-21
Citations
21k
34.9 per fractional work
Top-10% rate
21.8%
all institutions 10.0%
vs its own fields
1.11×
1.00× is exactly expected
Open access
30%
world 40%
International
28%
world 18%
Tennessee Oncology

What is Tennessee Oncology known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #2,562 of 9,902 23.0%101 #2428
MedicineField #2,878 of 8,541 23.2%96 #2638

Each strip is that field's whole ranked pool, with the notch where Tennessee Oncology sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Tennessee Oncology work in?

In 2022-now, 69% of research at Tennessee Oncology is in Health Sciences, 20% in Life Sciences. Its largest fields are Medicine (66%), Biochemistry, Genetics and Molecular Biology (16%), Economics, Econometrics and Finance (6%). It does 2.8× the world's share of Health Sciences.

Health Sciences: 112 fractional works · 69.2% of its workMedicine: 106 fractional works · 65.8% of its workOncology: 38 fractional works · 23.4% of its workPulmonary and Respiratory Medicine: 20 fractional works · 12.6% of its workRadiology, Nuclear Medicine and Imaging: 7 fractional works · 4.2% of its workHematology: 6 fractional works · 3.8% of its workPathology and Forensic Medicine: 5 fractional works · 3.0% of its workGenetics: 5 fractional works · 2.9% of its workPublic Health, Environmental and Occupational Health: 5 fractional works · 2.8% of its workSurgery: 4 fractional works · 2.3% of its workEpidemiology: 2 fractional works · 1.2% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.8% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.8% of its workNephrology: 1 fractional works · 0.7% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.7% of its workHepatology: 1 fractional works · 0.7% of its workReproductive Medicine: 1 fractional works · 0.6% of its workNeurology: 1 fractional works · 0.6% of its workPhysiology: 1 fractional works · 0.6% of its workOtorhinolaryngology: 1 fractional works · 0.5% of its workInfectious Diseases: 1 fractional works · 0.4% of its workDermatology: 1 fractional works · 0.4% of its workPsychiatry and Mental health: 1 fractional works · 0.3% of its workFamily Practice: 1 fractional works · 0.3% of its workHealth Informatics: 1 fractional works · 0.3% of its workRheumatology: 0 fractional works · 0.2% of its workOphthalmology: 0 fractional works · 0.2% of its workBiochemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 1.0% of its workHealth Professions: 4 fractional works · 2.5% of its workGeneral Health Professions: 2 fractional works · 1.2% of its workEmergency Medical Services: 1 fractional works · 0.9% of its workHealth Information Management: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDentistry: 1 fractional works · 0.6% of its workOral Surgery: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNursing: 1 fractional works · 0.3% of its workIssues, ethics and legal aspects: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workLife Sciences: 32 fractional works · 20.1% of its workBiochemistry, Genetics and Molecular Biology: 26 fractional works · 15.9% of its workMolecular Biology: 11 fractional works · 7.0% of its workCancer Research: 8 fractional works · 4.9% of its workGenetics: 4 fractional works · 2.5% of its workBiotechnology: 1 fractional works · 0.9% of its workCell Biology: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.3% of its workImmunology and Microbiology: 6 fractional works · 3.4% of its workImmunology: 5 fractional works · 3.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 1 fractional works · 0.5% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 0.1% of its workSocial Sciences: 13 fractional works · 8.1% of its workEconomics, Econometrics and Finance: 10 fractional works · 6.5% of its workEconomics and Econometrics: 10 fractional works · 6.5% of its workBusiness, Management and Accounting: 1 fractional works · 0.8% of its workAccounting: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 0.7% of its workHealth: 0 fractional works · 0.3% of its workSociology and Political Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 0.1% of its workPhysical Sciences: 4 fractional works · 2.6% of its workEngineering: 1 fractional works · 0.9% of its workBiomedical Engineering: 1 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 1 fractional works · 0.7% of its workRadiation: 1 fractional works · 0.6% of its workChemistry: 1 fractional works · 0.4% of its workOrganic Chemistry: 1 fractional works · 0.4% of its workComputer Science: 1 fractional works · 0.4% of its workArtificial Intelligence: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.2% of its workMaterials Chemistry: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.1% of its workALL ITS WORKTennesseeOncology161fractional works, 2022-now
Life Sciences20%Physical Sciences3%Health Sciences69%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine10665.8%
    2. Health Professions42.5%
    3. Dentistry10.6%
    4. Nursing10.3%
    1. Biochemistry, Genetics and Molecular Biology2615.9%
    2. Immunology and Microbiology63.4%
    3. Neuroscience10.5%
    4. Pharmacology, Toxicology and Pharmaceutics00.1%
    5. Agricultural and Biological Sciences00.1%
    1. Economics, Econometrics and Finance106.5%
    2. Business, Management and Accounting10.8%
    3. Social Sciences10.7%
    4. Decision Sciences00.1%
    1. Engineering10.9%
    2. Physics and Astronomy10.7%
    3. Chemistry10.4%
    4. Computer Science10.4%
    5. Materials Science00.2%
    6. Mathematics00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Tennessee Oncology specialise in?

Where its research is concentrated relative to its size: Oncology takes 20.8× the share of its output that it takes of world research.

  1. OncologySubfield · 37.7 works21×
  2. Pulmonary and Respiratory MedicineSubfield · 20.3 works8.2×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.03× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.98× its world share, 26 worksBiochemistry, Geneti…Immunology and Microbiology: 3.41× its world share, 6 worksImmunology and Micro…Neuroscience: 0.33× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.42× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.25× its world share, 1 worksChemistryComputer Science: 0.05× its world share, 1 worksComputer ScienceEngineering: 0.06× its world share, 1 worksEngineeringMaterials Science: 0.06× its world share, 0 worksMaterials ScienceMathematics: 0.09× its world share, 0 worksMathematicsPhysics and Astronomy: 0.29× its world share, 1 worksPhysics and AstronomyDentistry: 1.17× its world share, 1 worksDentistryHealth Professions: 0.94× its world share, 4 worksHealth ProfessionsMedicine: 3.42× its world share, 106 worksMedicineNursing: 0.70× its world share, 1 worksNursingBusiness, Management and Accounting: 0.26× its world share, 1 worksBusiness, Management…Decision Sciences: 0.10× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 3.03× its world share, 10 worksEconomics, Econometr…Social Sciences: 0.05× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.4×. Every wedge is a field page.

All 19 fields, with their numbers
  1. Medicine3.42×106 works
  2. Immunology and Microbiology3.41×6 works
  3. Economics, Econometrics and Finance3.03×10 works
  4. Biochemistry, Genetics and Molecular Biology2.98×26 works
  5. Dentistry1.17×1 works
  6. Health Professions0.94×4 works
  7. Nursing0.70×1 works
  8. Pharmacology, Toxicology and Pharmaceutics0.42×0 works
  9. Neuroscience0.33×1 works
  10. Physics and Astronomy0.29×1 works
  11. Business, Management and Accounting0.26×1 works
  12. Chemistry0.25×1 works
  13. Decision Sciences0.10×0 works
  14. Mathematics0.09×0 works
  15. Engineering0.06×1 works
  16. Materials Science0.06×0 works
  17. Computer Science0.05×1 works
  18. Social Sciences0.05×1 works
  19. Agricultural and Biological Sciences0.03×0 works

Who are the top researchers at Tennessee Oncology?

Ranked on the quality score, Todd Michael Bauer, Davey B. Daniel and Daniel J. Maslyar lead among researchers whose main affiliation is Tennessee Oncology.

  1. 1 Todd Michael Bauer United States · #26,295 worldwide 18k citations · 531 works
  2. 2 Davey B. Daniel United States · #139,175 worldwide 14k citations · 153 works
  3. 3 Daniel J. Maslyar United States · #260,862 worldwide 2.9k citations · 78 works
  4. 4 Kent C. Shih United States · #347,397 worldwide 4.7k citations · 91 works
  5. 5 Edward R. Arrowsmith United States · #368,463 worldwide 2.1k citations · 83 works
  6. 6 Sharlene Litchy United States · #706,517 worldwide 2.4k citations · 29 works
  7. 7 Tania Szado United States · #912,123 worldwide 3.7k citations · 50 works
  8. 8 Bertrand M. Anz United States · #1,139,192 worldwide 1.3k citations · 41 works
  9. 9 Stephen Matthew Schleicher United States · #1,175,177 worldwide 1.9k citations · 136 works
  10. 10 Lisa H. Morrissey United States · #1,213,432 worldwide 1.9k citations · 39 works
All ranked researchers at Tennessee Oncology

What are the most cited papers from Tennessee Oncology?

The most cited paper from Tennessee Oncology is "Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer" (Suzanne Louise Topalian et al., 2012), with 12,842 citations. Next come "Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer" (9,557) and "Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer" (8,632).

Most cited papers
#PaperReleasedCitations
1 Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer Suzanne Louise Topalian et al. · New England Journal of Medicine Open access 14 Jun 2012 12,842
2 Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer H. Borghaei et al. · New England Journal of Medicine Open access 27 Sep 2015 9,557
3 Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer Julie Renee Brahmer et al. · New England Journal of Medicine Open access 31 May 2015 8,632
4 Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine Daniel D. Von Hoff et al. · New England Journal of Medicine Open access 16 Oct 2013 6,826
5 Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma Sattva Swarup Neelapu et al. · New England Journal of Medicine Open access 10 Dec 2017 6,098
All 60 most cited papers, with filters and sorting

Which keywords describe research at Tennessee Oncology?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Targeted Therapy, Clinical Trials, Breast Cancer, Prognostic Factors, Tumor Microenvironment and Lymphoma.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy21▲ 18×22 topics
  2. Immunotherapy18▲ 16×15 topics
  3. Targeted Therapy17▲ 47×5 topics
  4. Clinical Trials14▲ 13×10 topics
  5. Breast Cancer13▲ 32×11 topics
  6. Prognostic Factors12▲ 18×13 topics
  7. Tumor Microenvironment10▲ 14×8 topics
  8. Lymphoma10▲ 37×3 topics
  9. Quality of Life9▲ 3.7×12 topics
  10. Cancer Immunotherapy8▲ 34×3 topics
  11. Metastatic Breast Cancer8▲ 85×2 topics
  12. Tumor Regression8▲ 44×2 topics
  13. Radiotherapy8▲ 12×11 topics
  14. Metastasis7▲ 13×12 topics
  15. Genomic Profiling7▲ 43×2 topics
  16. Treatment Guidelines7▲ 20×2 topics
  17. ALK Inhibitors7▲ 68×1 topic
  18. EGFR Mutations7▲ 68×1 topic
  19. CAR T Cells7▲ 56×1 topic
  20. Chimeric Antigen Receptor7▲ 56×1 topic
  21. Leukemia7▲ 49×2 topics
  22. Precision Medicine7▲ 8.3×6 topics
  23. Cost of Care6▲ 131×1 topic
  24. Financial Toxicity6▲ 131×1 topic
  25. Rituximab6▲ 26×2 topics
  26. Biomarkers6▲ 5.3×7 topics
  27. Cancer Therapy6▲ 6.5×14 topics
  28. Cell Cycle Control6▲ 102×2 topics
  29. Metastatic6▲ 53×2 topics
  30. Genomic Instability6▲ 30×3 topics
  31. PET Imaging6▲ 20×4 topics
  32. CDK4/6 Inhibitors5▲ 118×1 topic
  33. Palbociclib5▲ 118×1 topic
  34. Immune Checkpoint Blockade5▲ 29×1 topic
  35. PD-1 and PD-L15▲ 29×1 topic
  36. Monoclonal Antibody5▲ 58×2 topics
  37. Cancer Genomics5▲ 42×1 topic
  38. Mutational Signatures5▲ 42×1 topic
  39. Trastuzumab5▲ 57×2 topics
  40. EGFR4▲ 89×1 topic

Which research topics does Tennessee Oncology publish most on?

By volume in 2022-now: Lung Cancer Treatments and Mutations, CAR-T cell therapy research, Economic and Financial Impacts of Cancer and Advanced Breast Cancer Therapies.

Lung Cancer Treatments a…7Lung Cancer Treatments and Mutations: 7 fractional worksCAR-T cell therapy resea…7CAR-T cell therapy research: 7 fractional worksEconomic and Financial I…6Economic and Financial Impacts of Cancer: 6 fractional worksAdvanced Breast Cancer T…5Advanced Breast Cancer Therapies: 5 fractional worksCancer Immunotherapy and Biomarkers: 5 fractional worksCancer Genomics and Diagnostics: 5 fractional worksHER2/EGFR in Cancer Rese…4HER2/EGFR in Cancer Research: 4 fractional worksLung Cancer Research Stu…4Lung Cancer Research Studies: 4 fractional worksChronic Lymphocytic Leuk…3Chronic Lymphocytic Leukemia Research: 3 fractional worksLymphoma Diagnosis and T…3Lymphoma Diagnosis and Treatment: 3 fractional works
Pulmonary and Respiratory MedicineOncologyEconomics and EconometricsCancer Research2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 7 works
  2. 2 CAR-T cell therapy research Oncology 7 works
  3. 3 Economic and Financial Impacts of Cancer Economics and Econometrics 6 works
  4. 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 5 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 5 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 5 works
  7. 7 HER2/EGFR in Cancer Research Oncology 4 works
  8. 8 Lung Cancer Research Studies Oncology 4 works
  9. 9 Chronic Lymphocytic Leukemia Research Genetics 3 works
  10. 10 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.5%not open70.5%

World: 40% of research is openly available.

with international co-authors28.2%domestic only71.8%

World: 18% is written across borders.

How has Tennessee Oncology's research output changed?

Output in 2022-2025 was 1% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Tennessee Oncology as a percentage of every work published that year, 0.00050% in 2024.

still counting0.00050%0.0010%0.0015%Tennessee Oncology0.00065% in 202519801990200020102020

Fractional works of Tennessee Oncology over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%30%Tennessee Oncology17.5% in 2025all institutions10.0% in 20252020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 27.7% in 2021.

Other research institutions in Nashville

All research institutions in Nashville

Share Tennessee Oncology's ranking

Tennessee Oncology on Science Explorer

A card with Tennessee Oncology's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Tennessee Oncology. Posts are plain text and can be reported.